CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 103 filers reported holding CYTOSORBENTS CORP in Q2 2021. The put-call ratio across all filers is 2.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $174,000 | -23.7% | 54,600 | +0.2% | 0.00% | – |
| Q4 2021 | $228,000 | -48.5% | 54,500 | 0.0% | 0.00% | – |
| Q3 2021 | $443,000 | +7.8% | 54,500 | 0.0% | 0.00% | – |
| Q2 2021 | $411,000 | -9.5% | 54,500 | +4.2% | 0.00% | – |
| Q1 2021 | $454,000 | +8.9% | 52,300 | 0.0% | 0.00% | – |
| Q4 2020 | $417,000 | 0.0% | 52,300 | 0.0% | 0.00% | – |
| Q3 2020 | $417,000 | -19.5% | 52,300 | 0.0% | 0.00% | – |
| Q2 2020 | $518,000 | +51.5% | 52,300 | +18.3% | 0.00% | – |
| Q1 2020 | $342,000 | +302.4% | 44,200 | +100.9% | 0.00% | – |
| Q4 2019 | $85,000 | -23.4% | 22,000 | 0.0% | 0.00% | – |
| Q3 2019 | $111,000 | -23.4% | 22,000 | 0.0% | 0.00% | – |
| Q2 2019 | $145,000 | -3.3% | 22,000 | +11.1% | 0.00% | – |
| Q1 2019 | $150,000 | +66.7% | 19,800 | +78.4% | 0.00% | – |
| Q4 2018 | $90,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |